KRAS and neoplasm: In this model, on the one hand, the expression of Kras in the mouse pancreas accelerated the malignant development of pancreatic tumors, and on the other hand, caused species changes in the digestive tract microbiome as compared with littermates of wild-type mice, indicating that the gut microbiome alteration could likely be relevant to the enrichment in tumor-promoting bacteria.